Illumina, Inc.

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ILMNNASDAQ
HealthcareMedical - Diagnostics & Research
$190.25
$3.10(1.66%)
U.S. Market opens in 17h 20m

Illumina, Inc. (ILMN)

Meyka AI Score

Z

Key Financials

Market Cap28.8B
P/E Ratio33.83
EPS (TTM)$5.03
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$199.96
3 Months$222.98
1 Year Target$125.80

ILMN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (ILMN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $125.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 33.83 and a market capitalization of 28.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.12%
5-Day Change
-3.20%
1-Month Change
12.14%
3-Month Change
41.50%
6-Month Change
28.80%
Year-to-Date (YTD) Change
42.69%
1-Year Change
92.64%
3-Year Change
4.58%
5-Year Change
-58.36%
All-Time (Max) Change
883.45%

Contact Information

858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

89,700 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions